Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 3:9:507.
doi: 10.3332/ecancer.2015.507. eCollection 2015.

Fertility sparing treatment in borderline ovarian tumours

Rosa Maria Alvarez  1 , Daniel Vazquez-Vicente  2
Affiliations
Review

Fertility sparing treatment in borderline ovarian tumours

Rosa Maria Alvarez et al. Ecancermedicalscience. .

Abstract

Borderline ovarian tumours are low malignant potential tumours. They represent 10-15% of all epithelial ovarian malignancies. Patients with this type of tumour are younger at the time of diagnosis than patients with invasive ovarian cancer. Most of them are diagnosed in the early stages and have an excellent prognosis. It has been quite clearly established that the majority of borderline ovarian tumours should be managed with surgery alone. Because a high proportion of women with this malignancy are young and the prognosis is excellent, the preservation of fertility is an important issue in the management of these tumours. In this systemic review of the literature, we have evaluated in-depth oncological safety and reproductive outcomes in women with borderline ovarian tumours treated with fertility-sparing surgery, reviewing the indications, benefits, and disadvantages of each type of conservative surgery, as well as new alternative options to surgery to preserve fertility.

Keywords: borderline ovarian tumours; conservative treatment; fertility-sparing surgery.

PubMed Disclaimer

References

    1. Song T, et al. Fertility-sparing surgery for borderline ovarian tumors. Oncologic safety and reproductive outcomes. Int J Gynecol Cancer. 2011;21:640–6. doi: 10.1097/IGC.0b013e3182129842. - DOI - PubMed
    1. Morice P, et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13(3):e103–15. doi: 10.1016/S1470-2045(11)70288-1. - DOI - PubMed
    1. Abascal-Saiz A, et al. Management of borderline ovarian tumours: a comprehensive review of the literature. ecancer. 2014;8:403. - PMC - PubMed
    1. Bereka JS. FIGO cancer report 2012 cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet. 2012;119S2:S118–29. - PubMed
    1. Zanetta G, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658–64. - PubMed

LinkOut - more resources